19
Participants
Start Date
August 31, 2001
Primary Completion Date
January 31, 2003
Study Completion Date
June 30, 2005
MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine
Universtiy of Southern California/Kenneth Norris, Jr. Comprehensive Cancer Center, Los Angeles
University of Southern California
OTHER